Tg Therapeutics Inc (TGTX)

SG&A Expense Growth

-6.90%

Quarterly · Period ending:

TGTX logo

TGTX SG&A Expense Growth

Latest reported-6.90%
TGTX Quarterly SG&A Growth (QoQ) (0.00% → -6.90%)
High-resolution chart · PNG

TGTX sg&a expense growth history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Tg Therapeutics Inc SG&A Expense Growth — Quarterly
Period endingSG&A Expense Growth
-6.9%
40.5961%
-0.894%
13.8994%
10.4389%
29.1764%
-7.1558%
8.3889%
12.2293%
11.0685%
-5.2122%
-9.9233%
29.6102%
24.7245%
57.8785%
12.7868%
-38.6773%
-36.4155%
-7.1263%
2.5928%
27.1093%
-38.8339%
23.9602%
144.5337%
1.2131%
66.9125%
94.3585%
8.0629%
6.1864%
100.3661%
97.5207%
-82.9667%
-13.8548%
29.9462%
13.4716%
154.6386%
-65.0139%
181.6908%
-43.6856%
2.2891%
10.5409%
-29.157%
69.9541%
-67.9138%
13.9267%
6.8854%
19.3579%
-40.9579%
64.4719%
218.9663%
4.0379%
-22.8388%
-20.9516%
45.4068%
51.264%
-20.9353%
126.5273%
1,274.0898%
-133.0535%
-28.683%
10.3268%
-17.7028%
-8.1109%
-41.1724%
-7.3456%
42.8873%
-8.1953%
-17.1159%
-8.1546%
5,233.6109%
-98.9141%
-1.8671%
10.7459%
9.5479%
-17.2542%
-14.6631%
15.0483%
-27.1428%
33.2805%
4.2632%
1.4164%
18.1796%
53.5613%
-11.2564%
12.1476%
-9.6764%
-2.9619%
20.3091%
13.1926%
-22.1237%
28.5669%
-11.0197%
22.4276%
28.9527%
-36.5241%
40.8003%
-23.1479%
-4.0517%
-16.2411%
-54.8172%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.